Ajaypaul Sukhi
Interventional Cardiology · Omaha, NENPI 1205241502
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (48.2%), food and beverage and education — rather than concentrated in one kind of arrangement. 13 manufacturers reported payments, led by Boston Scientific at 40.4% of the total. Reporting peaked in 2023 at $3,444 and has fallen 96.1% since, to $133 in 2025.
Across 103 payments — averaging $89.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$4K
- Abbott$3K
- Medtronic$957
- E.r. Squibb & Sons, L.L.C.$355
- Shockwave Medical, Inc$257
- Edwards Lifesciences$214
- plus $706 from 7 others
What the payments were for
- Travel & lodging$4,43448%
- Food & beverage$4,29747%
- Education$4755%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 22 | $3,717 |
| Abbott | 30 | $2,999 |
| Medtronic | 8 | $957 |
| E.r. Squibb & Sons, L.L.C. | 17 | $355 |
| Shockwave Medical, Inc | 3 | $257 |
| Edwards Lifesciences | 3 | $214 |
| Astellas Pharma US Inc | 2 | $209 |
| Novartis | 4 | $175 |
| AstraZeneca | 3 | $135 |
| Johnson & Johnson | 7 | $108 |
| AbbVie | 2 | $39 |
| Philips North America LLC | 1 | $27 |
| Pfizer | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- THORATEC HEARTMATE 3 LVAS IMPLANT KIT$1,513
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$228
- ENSITE$156
- Edwards SAPIEN 3 Ultra Transcatheter Heart Valve$148
- CardioMEMS HF System$145
- OPTICROSS$134
- SYNERGY$133
- ENTRESTO$129
- BRILINTA$119
- Rotablator Rotational Atherectomy System Console Kit$109
- CARDIOMEMS$101
How this compares
$9,205 in reported general payments places this provider in the 60th percentile of 50 interventional cardiology providers in Nebraska.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ClopidogrelClopidogrel Bisulfate | 32 | $318 |
Paid to pharmacies, not to this prescriber.
Other interventional cardiology in Omaha
- Himanshu AgarwalOmaha$541K
- Poonam VelagapudiOmaha$142K
- Andrew GoldsweigOmaha$49K
- Jai ParekhOmaha$44K
- Scott CarolloOmaha$19K
- Shahbaz MalikOmaha$17K
- Toufik HaddadOmaha$14K
- Charles OlsonOmaha$12K
- Haysam AkkadOmaha$11K
- Filip OleszakOmaha$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.